Komori
Daicel (4202) · TargetFailure to meet the management targets for the final year

Management metrics focused on ROE and operating margin

First written in FY2017. 3 of 16 entries say "Raised", first in FY2018. Latest entry: FY2026.

16entries
10years
3from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019-Q1 – FY2020-Q1AdvancedFY2021 – FY20242017: 120172018: 220182019: 320192020: 120202021: 120212022: 120222023: 120232024: 120242025: 120252026: 42026
Same theme, other companies
Target for Improving Operating Margin and ROEA theme 38 companies write about · 1 as a headwind · 40 as a tailwind

The whole theme swung hardest in 2020: 9 of 26 companies on the "Worse" side.

7 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 38 companies compared. The sentences above are computed from all 38.
Full recordFilings, disclosures and news, newest first
  1. FY2026Failure to meet the management targets for the final yearAnnual report

    「In the final year of the medium-term strategy, the Company steadily captured sales opportunities arising from the recovery in demand and implemented thorough cost reductions. Net sales were ¥579.629 billion, down 1.2% year on year, and operating profit was ¥42.069 billion, down 31.0%.」

    For the final year of Accelerate 2025, the Company disclosed actual net sales and operating profit, showing that it fell short of its targets of ¥660.0 billion in net sales and ¥82.0 billion in operating profit, among others.
  2. FY2025ROE Below TargetAnnual report

    「For fiscal 2025, the final year of the medium-term strategy, the Company set the following company-wide performance and management targets: operating margin 12.4%, ROE 17.1%, ROIC 9.3%, ROA 7.7% and CCC 125 days. ROE was 13.8%, down 3.3 percentage points from the previous consolidated fiscal year. ROIC was 6.1% and EBITDA was ¥102.4 billion.」

    Against the fiscal 2025 target of ROE of 17.1%, ROE for the year was 13.8%, down 3.3 percentage points from the previous year.
  3. FY2024AdvancedAnnual report

    「ROE was 17.1%, an improvement of 2.7 percentage points from the previous consolidated fiscal year. ROIC was 6.3% and EBITDA was ¥96.1 billion.」

    ROE reached 17.1%, in line with the fiscal 2025 target, while the Company disclosed ROIC of 6.3% and EBITDA of ¥96.1 billion as actual results.
  4. FY2023AdvancedAnnual report

    「ROE was 14.3%, an improvement of 2.1 percentage points from the previous consolidated fiscal year. ROIC was 5.3% and EBITDA was ¥79.1 billion.」

    The Company disclosed ROE of 14.3%, ROIC of 5.3% and EBITDA of ¥79.1 billion as results against the fiscal 2025 targets, with ROE improving 2.1 percentage points from the previous year.
  5. FY2022AdvancedAnnual report

    「ROE was 12.3%, an improvement of 5.7 percentage points from the previous consolidated fiscal year. ROIC was 6.2% and EBITDA was ¥78.9 billion.」

    Against the fiscal 2025 targets under the new medium-term strategy, ROE was 12.3%, ROIC was 6.2% and EBITDA was ¥78.9 billion for the year, with ROE improving from the previous year.
  6. FY2021RaisedAnnual report

    「For fiscal 2025, the final year of the medium-term strategy, the Company set the following company-wide performance and management targets: operating margin 14.0%, ROE 18.0%, ROIC 10.0% and ROA 8.0%.」

    Following the end of the previous ROE target of 10% or higher, the Company set new management targets for fiscal 2025, including ROE of 18.0% and an operating margin of 14.0%. ROE for the current fiscal year was 6.6%.
  7. FY2020WorsenedAnnual report

    「To improve ROE over the medium to long term to a level above the cost of capital, the Group had aimed to maintain ROE at 10% or higher through the current consolidated fiscal year. However, in addition to the factors behind the decline in profit, impairment losses reduced net income attributable to owners of the parent, resulting in ROE of 1.3% for the consolidated fiscal year, down 7.8 percentage points from the previous consolidated fiscal year.」

    In the final year of the time-bound target of ROE of 10% or higher, ROE was 1.3%, down further from 9.1% the previous year.
  8. FY2020-Q1RestatedAnnual report

    「Under medium-term plan 3D-Ⅲ, the targets for the final year, fiscal 2019, are net sales of ¥500 billion and operating income of ¥70 billion. ROE and operating margin are treated as key management indicators. We will work to improve these indicators by increasing added value through the Best Solution, strengthening earnings power through thorough cost reductions and enhancing production capacity.」

    The Company continues to focus on ROE and operating margin and to improve them through higher added value, cost reductions and increased production capacity.
  9. FY2019ROE target not achievedAnnual report

    「To improve ROE over the medium to long term to a level above the cost of capital, the Group aims to maintain ROE at 10% or higher through fiscal 2019. ROE for the consolidated fiscal year was 9.1%, down 0.7 percentage points from the previous consolidated fiscal year.」

    Against the target of ROE of 10% or higher through fiscal 2019, ROE for the year was 9.1%, below the target level.
  10. FY2019-Q3RestatedAnnual report

    「Under medium-term plan 3D-Ⅲ, the targets for the final year, fiscal 2019, are net sales of ¥500 billion and operating income of ¥70 billion. ROE and operating margin are treated as key management indicators. We will work to improve these indicators by increasing added value through the Best Solution, strengthening earnings power through thorough cost reductions and enhancing production capacity.」

    The Company continues to focus on ROE and operating margin and to improve them through higher added value, cost reductions and increased production capacity.
  11. FY2019-Q1RestatedAnnual report

    「Under medium-term plan 3D-Ⅲ, the targets for the final year, fiscal 2019, are net sales of ¥500 billion and operating income of ¥70 billion. ROE and operating margin are treated as key management indicators. We will work to improve these indicators by increasing added value through the Best Solution, strengthening earnings power through thorough cost reductions and enhancing production capacity.」

    The Company continues to focus on ROE and operating margin as key metrics, and has set performance targets for fiscal 2019 and identified improvement measures involving higher added value, cost reductions and increased production capacity.
  12. FY2018RaisedAnnual report

    「To improve ROE over the medium to long term to a level above the cost of capital, the Group aims to maintain ROE at 10% or higher through fiscal 2019. It will work to improve these metrics by increasing added value through best solutions, strengthening profitability through thorough cost reductions, and improving production capacity.」

    The Company specified a concrete target of maintaining ROE at 10% or higher through fiscal 2019 as a level above the cost of capital, together with measures to achieve it.
  13. FY2017First statedAnnual report

    「<Key management metrics> Return on equity (ROE), operating margin」

    3D-III explicitly identified ROE and operating margin as standalone key management metrics for the first time.
Moved together

"Profit allocation combining performance-linked dividends and retained earnings" moved the same way as this thread, in the same document, in 6 of its 16 moves.

665555★123456
  1. ★This thread
  2. 1Profit allocation combining performance-linked dividends and retained earnings6×
  3. 2Enhancing the competitiveness of equipment-based industries through production innovation methods6×
  4. 3Strengthening Technology and Product Discovery and Commercialization Capabilities5×
  5. 4Building the healthcare business5×
  6. 5Development of functional materials in the electronics and medical fields5×
  7. 6Reinvestment of retained earnings in research and development and capital expenditure5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Daicel's next results are scheduled for 2026-11-05. Read the earnings preview It last moved in the Earnings presentation of 2026-05-22: "Raised".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.